newsfilter
← Latest News
Business Wire·

MorphoSys Appoints Tim Demuth as New Chief Research and Development Officer, Following the Retirement of Malte Peters

Tim Demuth, M.D., Ph.D., has more than 20 years of broad leadership experience in drug development, with a focus in oncology MorphoSys AG ((FSE: MOR, NASDAQ:MOR) announced today that Malte Peters, M.D., the company's Chief Research and Development Of